NVDA
NVIDIA Corporation
NVDA has the edge over STNE overall, supported by stronger valuation and stronger modeled upside.
STNE
StoneCo Ltd.
STNE trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
STNE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
STNE's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over STNE in the historical PE scenario, which offers more potential upside but is not a forecast.
STNE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 3.3x | $7.72 | — |
| Cheap | 7.7x | $17.74 | +130% |
| Fair | 61x | $141 | +1729% |
| Expensive | 131x | $303 | +3821% |
Historical ranges are pointers, not guarantees.
STNE's PE is 3.3x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
STNE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect STNE's profitability to improve, with its earnings and revenue holding steady.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over STNE on earnings, with more consistent year-over-year improvement.
STNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.31 | +$3.07 |
| Q1 2026 | $2.37 | +$3.23 |
| Q4 2025 | $1.49 | +$2.46 |
| Q3 2025 | -$0.64 | -156% |
| Q2 2023 | $0.44 | +$2.08 |
| Q1 2023 | $0.00 | +$0.97 |
| Q4 2022 | -$0.30 | +$0.39 |
| Q3 2022 | -$0.79 | -$0.74 |
STNE has returned to profit: it earned $2.31 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over STNE on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over STNE on profitability, with a higher operating margin.
STNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $597.5M | +1.6% |
| Q1 2026 | $640.6M | +13% |
| Q4 2025 | $633.7M | +1.4% |
| Q3 2025 | $638.6M | +11% |
| Q2 2025 | $588.4M | +18% |
| Q1 2025 | $569.3M | +20% |
| Q4 2024 | $625M | +13% |
| Q3 2024 | $575.3M | +8.8% |
STNE's revenue has grown year over year every quarter since late 2020: $598M last quarter, up 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 41% | -6.9 points |
| Q1 2026 | 51% | +1.9 points |
| Q4 2025 | 51% | +2.9 points |
| Q3 2025 | 56% | +10 points |
| Q2 2025 | 48% | -1.1 points |
| Q1 2025 | 49% | +0.4 points |
| Q4 2024 | 48% | +1.1 points |
| Q3 2024 | 46% | -1.6 points |
STNE's operating margin was 41% last quarter, down 6.9 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over STNE on cash flow, with more consistent year-over-year improvement.
STNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $303.4M | +2369% |
| Q1 2026 | $555M | +820% |
| Q4 2025 | $99.1M | +$210.6M |
| Q3 2025 | -$236.2M | -$159.3M |
| Q2 2025 | $12.3M | +$202.2M |
| Q1 2025 | $60.3M | +$558M |
| Q4 2024 | -$111.6M | +$6.5M |
| Q3 2024 | -$76.9M | -$56.7M |
STNE's free cash flow has turned positive after two years mostly in the red: $721M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
STNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.2% | -8M shares |
| 1 year | -11% | -30.5M shares |
| 3 years | -27% | -93M shares |
| 5 years | -22% | -69.4M shares |
| Available history | -13% | -36.8M shares |
STNE has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $139.1M |
| Q1 2026 | $93.4M |
| Q4 2025 | $235.8M |
| Q3 2025 | $83.3M |
| Q2 2025 | $71.2M |
| Q1 2025 | $151M |
| Q4 2024 | $108.9M |
| Q3 2024 | $132.9M |
STNE spent $552M buying back its own shares over the past year, up 19% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over STNE on leverage, with a lower net debt burden relative to earnings.
STNE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.2x | Healthy |
| Q3 2024 | 0.9x | Very low |
STNE's net debt is about 1.4 years of its operating earnings (EBITDA), about the same as a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
STNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.0 | Neutral |
| Stochastic | 11.0 | Oversold |
STNE's weekly RSI is 37 (neutral) and its Stochastic is 11 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
STNE PE vs Technology Sector
| Metric | STNE | Sector median | Relative |
|---|---|---|---|
| PE | 3.3x | 28x | 88% below |
| PE % | 1 | 35 | 34 pts below |
STNE has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over STNE on trend strength, trading above more of its moving averages.
STNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.63 | 20% below |
| 20 week MA | $10.1 | 23% below |
| 50 week MA | $12.3 | 37% below |
| 100 week MA | $12.9 | 40% below |
| 200 week MA | $12.9 | 40% below |
STNE is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over STNE on returns for 2026, with the stronger performance.
STNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.1 | $85.2 | +118% |
| 2021 | $85.2 | $17.4 | -80% |
| 2022 | $17.4 | $9.60 | -45% |
| 2023 | $9.60 | $18.0 | +88% |
| 2024 | $18.0 | $8.19 | -55% |
| 2025 | $8.19 | $14.8 | +81% |
| 2026 YTD | $14.8 | $7.72 | -48% |
STNE's yearly returns have swung widely, from +118% in 2020 to −80% in 2021. It's down 48% so far in 2026.